1 Day
Source:
Financial Times
AstraZeneca and Bristol-Myers merge
Enlarged balance sheets enable companies to make larger investments in potential blockbuster drugs, leveraging their financial strength. This increased capacity supports higher-risk, high-reward ventures in the pharmaceutical industry.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)